The Recall Desk
HighFDA (Drugs)·D-0587-2023·Announced 2023-05-24

Ampicillin for Injection Recalled Due to Sterility Assurance Defect

Astral SteriTech Private Ltd. is recalling Ampicillin for Injection due to manufacturing controls that cannot assure product sterility. The FDA Class II recall affects approximately 80,850 vials distributed nationwide.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II recall with a sterility assurance defect affecting an injectable antibiotic. The manufacturing control failure creates a risk of microbial contamination in a high-risk product form (injectable). This qualifies as a risk-of-harm product where injury has not yet been reported, per the rubric.

Plain-English summary

Ampicillin for Injection, USP 1g per vial is being recalled due to lack of assurance of sterility in the manufacturing process. The product is distributed nationwide under NDC 70594-086-02.

The recall affects approximately 80,850 vials. All lots currently within expiry are included. This is an FDA Class II recall initiated by Astral SteriTech Private Ltd., the manufacturer, with product distributed for Xellia Pharmaceuticals USA.

Healthcare providers and patients with questions about current or recent use of this product should consult their healthcare provider for guidance.

The recalled product

Product
Ampicillin for Injection, USP 1g per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-086-02
Manufacturer
Astral SteriTech Private Ltd.
Category
Drug — Antibiotic Injectable
Hazard
  • sterility-assurance
  • contamination-risk

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry.

Distribution

Distributed nationwide across the United States.

Related recalls

Same category